Back to search

Article

Chronotherapy as a Potential Strategy to Reduce Ifosfamide-Induced Encephalopathy: A Preclinical Study in a Murine Model

2025-09-03

Abstract excerpt

<h4>Purpose</h4> Nearly five decades after its introduction into clinical oncology, ifosfamide (IFO) remains a widely used alkylating chemotherapeutic agent for the treatment of sarcomas, germ-cell tumors and selected hematological malignancies in both adult and pediatric oncology. Its use is limited by severe toxicities, particularly hemorrhagic cystitis and central nervous system complications. Recent studies h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d7293c7c-b5f1-5307-b164-4bd087112c6b
DOI
10.1101/2025.08.28.672634
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chronotherapy as a Potential Strategy to Reduce Ifosfamide-Induced Encephalopathy: A Preclinical Study in a Murine ModelDOI 10.1101/2025.08.28.672634
Select a neighboring publication to make it the new centre.